Wilmington Savings Fund Society FSB lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 24,767.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 9,947 shares of the company’s stock after buying an additional 9,907 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Astera Labs were worth $1,317,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in ALAB. Hollencrest Capital Management acquired a new stake in Astera Labs during the third quarter worth approximately $26,000. Geneos Wealth Management Inc. bought a new position in shares of Astera Labs during the 4th quarter worth approximately $36,000. ORG Wealth Partners LLC acquired a new stake in shares of Astera Labs during the 4th quarter worth approximately $42,000. US Bancorp DE bought a new stake in shares of Astera Labs in the 3rd quarter valued at $46,000. Finally, First Horizon Advisors Inc. bought a new position in Astera Labs during the third quarter worth $49,000. 60.47% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
ALAB has been the subject of several research analyst reports. Barclays lifted their price target on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Finally, Roth Mkm increased their target price on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $107.42.
Astera Labs Trading Down 3.1 %
NASDAQ ALAB opened at $101.29 on Monday. The company has a fifty day moving average price of $122.39 and a 200-day moving average price of $81.91. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.
Insiders Place Their Bets
In related news, CFO Michael Truett Tate sold 16,000 shares of Astera Labs stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.84, for a total transaction of $1,885,440.00. Following the sale, the chief financial officer now directly owns 1,412,888 shares in the company, valued at approximately $166,494,721.92. This trade represents a 1.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 2,513 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $228,205.53. Following the completion of the transaction, the general counsel now owns 248,745 shares of the company’s stock, valued at $22,588,533.45. This trade represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 846,452 shares of company stock valued at $86,427,256.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- What is Put Option Volume?
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.